[Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
Lindner
C
C
Abteilung für Klinische und Experimentelle Endokrinologie, Universitäts-Frauenklinik Hamburg, Eppendorf.
Braendle
W
W
Lichtenberg
V
V
Bettendorf
G
G
D002064:Buserelin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D007006:Hypogonadism / Q000628:therapy*; D007247:Infertility, Female / Q000628:therapy*; D008596:Menotropins / Q000008:administration & dosage*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D017329:Triptorelin Pamoate
D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D002064:Buserelin
Kombinierte GnRH-Agonist/hMG-Therapie und ovarielles Uberstimulations-syndrom.